Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction.

[1]  B. Pitt,et al.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.

[2]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[3]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[4]  W. Rogers,et al.  Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD]). , 1991, American Journal of Cardiology.

[5]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[6]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[7]  Salim Yusuf,et al.  Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. , 1990, The American journal of cardiology.

[8]  J. Kostis Angiotensin converting enzyme inhibitors. II. Clinical use. , 1988, American heart journal.

[9]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[10]  A. Crisp 'Biological' depression; because sleep fails? , 1986, Postgraduate medical journal.

[11]  S. Gottlieb,et al.  Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management. , 1986, Postgraduate medical journal.

[12]  S. Ball,et al.  Severe hypotension after first dose of enalapril in heart failure. , 1985, British medical journal.

[13]  M. Wilén,et al.  Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. , 1985, Journal of the American College of Cardiology.

[14]  D. Sharpe,et al.  Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. , 1984, Circulation.

[15]  S. Textor,et al.  Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure. , 1984, British heart journal.

[16]  M. Packer,et al.  Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. , 1983, Circulation.

[17]  E. Espiner,et al.  Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. , 1983, British heart journal.

[18]  J. Halperin,et al.  Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. , 1981, American heart journal.

[19]  D. Mason,et al.  Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. , 1981, American heart journal.

[20]  J. Cohn,et al.  Acute and Long‐term Response to an Oral Converting‐enzyme Inhibitor, Captopril, in Congestive Heart Failure , 1980, Circulation.

[21]  N. Hollenberg,et al.  Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. , 1980, The New England journal of medicine.

[22]  B. Brundage,et al.  Immediate and Sustained Hemodynamic and Clinical Improvement in Chronic Heart Failure by an Oral Angiotensin‐converting Enzyme Inhibitor , 1980, Circulation.

[23]  T. Ryan,et al.  Angiotensin Converting Enzyme Inhibition in Patients with Congestive Heart Failure , 1978, Circulation.